Dignified Food for Seniors: Closing Gaps in an Ageing World
Singapore’s Institute of Technology (SIT) has unveiled MAKANsoft, a halal‑certified food texturant that reshapes puréed dishes into familiar forms while meeting IDDSI Levels 4‑5. The innovation tackles choking risks and the loss of dignity for seniors with dysphagia, costing roughly SG$2 (US$1.6) per person per day in care settings. MAKANsoft is being rolled out with B2C and B2B partners under the DIGNIFIED programme backed by A*STAR. It targets the rapidly aging Asian market, where culturally appropriate texture‑modified meals are in short supply.
AI Model Helps Discern Patients' Need for Supplemental Breast Imaging
A deep‑learning model called Mirai, developed by MIT and Mass General, predicts a woman’s five‑year breast‑cancer risk from routine mammograms with an AUROC of 0.71, markedly higher than the 0.53 achieved by traditional density‑based BI‑RADS categories. The study evaluated over...
Comparing Antibiotic Outcomes in Preterm Infants
A recent multicenter cohort study examined how different antibiotic regimens affect outcomes in preterm infants born before 32 weeks. Researchers compared broad‑spectrum empiric therapy with a targeted, shorter‑duration approach, tracking mortality, necrotizing enterocolitis (NEC), late‑onset sepsis, and antimicrobial resistance. The...
Is the Atrium-WakeMed Merger Already Hitting a Wall?
North Carolina’s two largest health systems, Atrium Health and WakeMed, announced a $2 billion merger that would create 3,300 jobs in Wake County. The Wake County Board of Commissioners postponed its vote, citing transparency and cost concerns raised by the state...
Disruptions Threaten Progress in Inclusive Clinical Trials and Health Equity
JMIR Publications highlighted recent disruptions to inclusive clinical trials after a 2025 White House executive order targeting DEI programs. The order led to the termination and delayed funding of NIH‑funded studies, such as Dr. Mohottige’s kidney disease trial, affecting 383...
Study Finds Weak Penalties for Medicare Advantage Rule Violations
A Brown University study published in JAMA Internal Medicine examined CMS enforcement of Medicare Advantage plans from 2010‑2023. It found that 87% of the 844 actions were modest monetary penalties, with fines averaging under $3 per enrollee and a peak...
TGA Updates Australian Manufacturing Licences with New Approvals and Regulatory Actions
The Therapeutic Goods Administration (TGA) released its latest licensing decisions, granting 14 new manufacturing licences for therapeutic goods while suspending two and revoking eight existing licences. The approvals cover a diverse set of entities, including pharmaceutical firms, biotech innovators, logistics...
Former Governor Joins Radiology Partners Board of Directors
Radiology Partners, the nation’s largest physician‑owned radiology practice, announced that former Maryland Governor Larry Hogan has joined its board of directors. Hogan, who served from 2015 to 2023, led the state’s $216 million Cancer Moonshot initiative and survived stage 3 non‑Hodgkin lymphoma...
Advances in Neonatal Cell Therapies: 2025 Update
The 2025 Neonatal Cell Therapies Symposium underscored the rapid maturation of manufacturing for cord blood, placental and amniotic‑derived cellular products, now operating under GMP certification. Robust quality‑management systems integrate donor eligibility, informed consent and continuous environmental monitoring to guarantee batch...
Depression Worsens Rapidly in the Final Four Years of Life
A multinational twin study of 2,411 older adults found that depressive symptoms sharply accelerate about four years before death. The acceleration is more pronounced in men, who experience steeper increases after the four‑year mark, while women’s rise begins slightly earlier....
CB Exclusive: Mosh Puts Family Judgement in the Spotlight for New Weight Loss Campaign
Mosh and its women‑focused brand Moshy have launched a "Weight Loss Without The Judgement" campaign that puts family criticism at the centre of a POV horror‑style video. The spot, directed by in‑house talent Yarno Rohling, dramatizes unsolicited advice during dinner...
Cytokinetics Inc (CYTK) Q1 2026 Earnings Call Transcript
Cytokinetics reported a strong commercial debut for MYCorzo, generating $4.8 million in product revenue within the first nine weeks and securing an $11.9 million Bayer milestone payment. The drug saw rapid adoption, with over 425 prescribers and 70% of dispensed...
Neuronetics Inc (STIM) Q1 2026 Earnings Call Transcript
Neuronetics reported Q1 2026 results highlighting an 86% revenue surge to $41.8 million, driven largely by the integration of Greenbrook clinic operations. The company posted a net loss of $7.2 million, but achieved positive operating cash flow in the fourth...
Viemed Healthcare Inc (VMD) Q1 2026 Earnings Call Transcript
Viemed Healthcare reported a 14.7% year‑over‑year revenue increase in Q2 2025, driven entirely by organic growth, with its core ventilation business still contributing 54% of sales. Sleep therapy patients rose 15% sequentially, making sleep the fastest‑growing segment, while the resupply...
Ocugen Inc (OCGN) Q1 2026 Earnings Call Transcript
Ocugen reported major clinical progress across its gene‑therapy pipeline, completing enrollment for the OCU400 Phase 3 Limelight trial and delivering strong 12‑month efficacy data for OCU410 in geographic atrophy and OCU410ST in Stargardt disease. The company announced a rolling Biologics License...
Community Healthcare Trust Inc (CHCT) Q1 2026 Earnings Call Transcript
Community Healthcare Trust reported Q1 2026 revenue of $30.9 million, a 5.6% year‑over‑year increase, while funds from operations rose 4.6% to $13.3 million. The REIT lifted its quarterly dividend to $0.4775 per share, annualizing $1.91, and maintained occupancy at 90% with a...
Jazz Pharmaceuticals PLC (JAZZ) Q1 2026 Earnings Call Transcript
Jazz Pharmaceuticals reported a record $1.126 billion third‑quarter revenue, up 7% year‑over‑year, driven by double‑digit growth in its sleep franchise and Epidiolex. Xywav sales rose 11% to $431 million with 450 net patient adds, while Epidiolex posted a 20% increase to $303 million....
AtriCure Inc (ATRC) Q1 2026 Earnings Call Transcript
AtriCure reported $534.5 million revenue for 2025, a 15% increase year‑over‑year, with adjusted EBITDA rising to $61.8 million and cash generation of $45 million. Gross margin held steady at 75% and the company launched two new products, the AtriClip Pro Mini and Cryo XT...
Cumberland Pharmaceuticals Inc (CPIX) Q1 2026 Earnings Call Transcript
Cumberland Pharmaceuticals reported an 18% revenue increase to $44.5 million for 2025, driven by strong sales of Vibativ, Sancuso and the newly launched Talicia. Adjusted earnings turned positive at $1.7 million and cash flow from operations rose to $4.9 million, narrowing the annual...
Alkermes Plc (ALKS) Q1 2026 Earnings Call Transcript
Alkermes reported $1.5 billion in 2025 revenue, driven by a 9% rise in its proprietary product portfolio, and closed the $775 million cash Avadel acquisition in February 2026, adding the LUMRIZE sleep‑medicine platform. The company forecast 2026 total revenue of $1.73‑$1.84 billion with...
DaVita Inc (DVA) Q1 2026 Earnings Call Transcript
DaVita reported adjusted operating income of $439 million and adjusted EPS of $2 for Q1 2026, surpassing its own guidance thanks to disciplined expense management and higher reimbursement from phosphate binders. Treatment volume fell 40 basis points year‑over‑year, prompting a revised...
Exelixis Inc (EXEL) Q1 2026 Earnings Call Transcript
Exelixis reported first‑quarter 2026 revenue of $611 million, driven by an $555 million cabozantinib franchise that grew 8% year‑over‑year and lifted global sales to $764 million, a 12.5% increase. The company posted record new patient starts for CABOMETYX, expanding its renal cell carcinoma...
Supernus Pharmaceuticals Inc (SUPN) Q1 2026 Earnings Call Transcript
Supernus Pharmaceuticals announced FDA approval of Qelbree, a non‑controlled ADHD medication for children aged 6‑17, with a U.S. launch planned for the second quarter of 2021. The company reported first‑quarter revenue of $130.9 million, a 38% year‑over‑year increase, driven by growth...
Adaptive Biotechnologies Corp (ADPT) Q1 2026 Earnings Call Transcript
Adaptive Biotechnologies reported $277 million total revenue for 2025, a 55% year‑over‑year increase, driven by a 46% jump in MRD revenue to $212 million and a 43% rise in clonoSEQ test volume to 30,038. Average selling price per test climbed 17% to...
Fasting Opens a Metabolic Window that Favors Anti-Tumor Immunity
Short‑term fasting reshapes the tumor microenvironment by temporarily increasing intratumoral isoleucine, creating a metabolic niche that cytotoxic CD8⁺ T cells can exploit. The study by Chen et al. shows that a 16‑hour fast elevates isoleucine levels, enhancing T‑cell effector programs and...
NIH Grant Cuts Disproportionately Hit Minority and Female Scientists
In early 2025 the Trump administration ordered the termination of more than 2,000 NIH biomedical research grants, many of which were later reinstated after university negotiations and lawsuits. A survey of roughly 940 affected investigators shows that the cuts fell...
Neurocrine Biosciences Inc (NBIX) Q1 2026 Earnings Call Transcript
Neurocrine Biosciences reported Q1 2026 results with total product sales exceeding $2.8 billion, a 22% year‑over‑year increase driven by strong performance of INGREZZA and the first‑year launch of CRENESSITY. INGREZZA generated over $2.5 billion, up 9%, while CRENESSITY posted more than $300 million, covering...
AI in Cancer Research Waits for Its Funding Moment
General‑purpose AI attracted $33.9 billion in 2024, while the AI‑in‑cancer market was valued at $2.45 billion, just 7 % of that total. Researchers at the University of Hong Kong unveiled MorphoGenie, an unsupervised deep‑learning tool that extracts subtle patterns from cell images, following...
Vertex Drops mRNA Cystic Fibrosis Program over 'Tolerability' Issues
Vertex Pharmaceuticals announced it is halting development of its mRNA‑based cystic fibrosis (CF) therapy after encountering tolerability and delivery challenges. The decision follows similar setbacks at other biotech firms pursuing mRNA treatments for CF. Vertex will refocus resources on its...
Oklahoma Amends Medical Marijuana Law: Employers Lose Discretion to Designate ‘Safety-Sensitive’ Positions
Oklahoma’s medical‑marijuana statute has been amended by House Bill 3127 to impose a zero‑tolerance drug and alcohol standard for employees in designated “safety‑sensitive” positions. The amendment removes employer discretion in defining those roles, limiting the definition to nine specific duties...
DOJ Moves Certain Marijuana Products to Schedule III, Sets June Rescheduling Hearing
The U.S. Department of Justice issued an order on April 22, 2026 moving FDA‑approved and state‑licensed medical marijuana products into Schedule III of the Controlled Substances Act. A separate order sets a June 29, 2026 hearing to consider broader rescheduling of marijuana from Schedule I to...
All-or-Nothing: Inside CMS Audits of Nursing Home Quality Measures and Their Impact on Reimbursement and Star Ratings
CMS has launched a new data‑validation audit for nursing homes under the Quality Reporting Program, selecting about 1,500 facilities (roughly 10% of the 15,300 certified homes) in early 2026. Facilities must acknowledge the notice within five business days and submit...
Comer Targets CPT System ‘Complexity,’ Citing Concerns Over Fraud, Rising Health Spending
House Oversight Committee Chairman James Comer warned that the American Medical Association’s Current Procedural Terminology (CPT) code system is overly complex, creating loopholes for fraud and inflating federal health‑care spending. He has asked the Centers for Medicare & Medicaid Services...
The Prognostic Nutritional Index (PNI) and Sepsis-Induced Cardiomyopathy (SCM) Risk in the ICU: A Retrospective Study with L-Shaped Analysis
A retrospective analysis of 200 ICU sepsis patients found that the prognostic nutritional index (PNI) is inversely associated with sepsis‑induced cardiomyopathy (SCM). SCM occurred in 63% of the cohort, with incidence dropping from 83% in the lowest PNI tertile (<31.3)...
Body Mass Index and Dietary Intake as Nutritional Determinants of Sarcopenia in Older Adults
A retrospective study of 360 adults aged 60 and older found that 11.4% met sarcopenia criteria. Lower body‑mass index, reduced daily energy, protein, and dietary fiber intakes were each independently linked to higher odds of sarcopenia after adjusting for age,...
Blood Stem Cells Evade Immune Attack in Aplastic Anemia Through Gene Mutations
Scientists at St. Jude Children’s Research Hospital analyzed 619 aplastic anemia patients and discovered that multiple independent gene mutations in blood stem cells silence the disease‑triggering HLA risk allele, allowing those cells to evade autoimmune attack. Overall, 69% of patients...
State Lawmakers Push Emergency Prep Overhaul in Nursing Homes, Citing Past Saber Facility Fire
Pennsylvania lawmakers introduced a bill that would require nursing homes to share their emergency response plans with local police, fire and rescue agencies. The legislation was spurred by the deadly Saber Healthcare explosion in Bristol, which left three residents dead...
ACR Elects New Officers
The American College of Radiology (ACR) elected Alan H. Matsumoto, MD, MA, FACR, as president and David Larson, MD, MBA, FACR, as vice president during its May 4, 2026 annual meeting in Washington, D.C. Matsumoto, the outgoing chair of the Board of...
Early Field Observations Provide Preliminary Consistency with Prior Concerns on Neonatal Outcomes in Gaza
Recent field reports from Gaza indicate a sharp rise in adverse neonatal outcomes, with congenital malformations reportedly doubling and stillbirths increasing by roughly 140% between 2022 and 2025. The observations, cited by Al Jazeera and local health authorities, align with...
AHA Podcast: Reducing Stigma in Substance Use Disorder Care
In a recent AHA podcast, three leaders from CommonSpirit Health detailed how the system is tackling stigma around substance‑use disorder (SUD) through education, storytelling, language reform, and grassroots culture change. They explained that shifting terminology, providing staff training, and amplifying...
Webinar to Explore AI Use in Cybersecurity, Health Care Technology
A joint webinar hosted by the American Hospital Association and the Joint Commission will explore how artificial intelligence can strengthen cybersecurity in health‑care settings. The event highlights the newly launched Cyber Resilience Readiness program, recent guidance from CISA and the...
AHA, Joint Commission Announce Cybersecurity Readiness Effort
The American Hospital Association and the Joint Commission unveiled the Cyber Resilience Readiness program, a voluntary initiative designed to help hospitals and health systems sustain safe, quality clinical operations during cyber‑related outages lasting 30 days or more. Unlike traditional IT‑focused...
Beyond Antibiotics: Why the Next Great Medical Battle Is Against Fungus
Drug‑resistant fungi are emerging as a global health crisis, outpacing research and treatment options. Experts led by Prof. Paul Verweij have highlighted a silent surge in resistance across common and invasive infections, from athlete's foot to deadly candidemia. A coalition...
FDA Expectations Create Potential Friction in New Form 483 Response Guidance
The FDA has issued a draft guidance outlining heightened expectations for Form 483 response submissions, emphasizing greater detail and faster turnaround. Cooley’s life‑sciences regulatory chair, Sonia Nath, warned that these demands could generate friction between regulators and manufacturers. She urged...
Wearable Technology Impacts Hospice Staff Safety, Satisfaction
Wearable safety devices are gaining traction among home‑based hospice staff, who confront heightened physical and psychosocial risks. Silent Beacon, founded in 2016, offers a wearable with a panic button, location tracking, and instant communication to streamline emergency response. Research cited...
Utilization of Modern Family Planning Methods and Associated Factors Among Men Aged 15- 54 Years in Pakwach District Uganda: A...
A cross‑sectional survey of 302 men aged 15‑54 in Pakwach District, Uganda, found that only 45.4% reported using condoms and none had undergone vasectomy, indicating very low modern family‑planning (FP) uptake. Logistic regression identified three significant predictors: comfort discussing FP...
SimonMed Deploys AIRS Medical to Power AI-Enhanced MRI Across National Network
SimonMed, a leading independent outpatient imaging provider, announced the enterprise‑wide deployment of AIRS Medical’s FDA‑cleared SwiftMR AI solution across its national MRI network. The AI platform promises sharper images, up to 30% faster scan times, and consistent performance on multi‑vendor...
Confluent Medical Technologies Opens Nitinol Wire Manufacturing Facility in India
Confluent Medical Technologies has launched a 26,000‑square‑foot Nitinol Wire Center of Excellence in Hyderabad, India, effectively doubling its nitinol wire output. The ISO 13485‑certified facility offers four‑week lead times for wire diameters ranging from 0.004 in. to 0.100 in. with ultra‑tight tolerances. By...
Delayed hCG Trigger Does Not Improve Oocyte Maturation Rate: Evidence From 9,319 IVF/ICSI Cycles Using Three Controlled Ovarian Hyperstimulation Protocols
A retrospective cohort of 9,319 first‑time IVF/ICSI cycles in China examined whether the proportion of dominant follicles at hCG trigger influences oocyte maturation. Across depot GnRHa, long GnRHa, and antagonist protocols, overall DFP showed no significant impact on maturation rates,...
The Challenges of Independent Rural Healthcare Practices
Independent rural healthcare practices are grappling with mounting financial pressures, especially from Medicaid’s cumbersome administrative requirements and thin reimbursement rates. Staffing shortages and limited access to capital further restrict their ability to adopt new technologies or expand services. The shift...